LECTURE 13 (Cancer II) Flashcards
Why do immune responses often fail to check tumour growth?
Since tumours evolve in the host to evade immune recognition or resist immune effector mechanisms
What are the different ways that Tumours evade immune response?
- Stop expressing the antigens that are targets of immune attack “Antigen loss variants”
[if lost antigen is not involved in maintaining the malignant properties of tumour -> variant tumour cells continue to grow + spread] - Tumours stop expressing class I MHC molecules -> cannot display antigens to CD8+ T cells
[BUT NK cells are activated when target cells lack MHC I molecules -> NK cells can kill MHC I negative tumours] - Secrete cytokines like TRANSFORMING GROWTH FACTOR β that suppress immune responses
- Express ligands for T cell inhibitory receptors such as PD-1 + induce low levels of B7 co-stimulators on APC resulting in binding of inhibitory receptors rather than stimulatory receptor
- Induce regulatory T cells -> suppress anti-tumour immune responses
NET RESULT IS REDUCED T CELL ACTIVATION
What are the main strategies for cancer immunotherapy?
- To provide anti tumour effectors (antibodies and T cells) to patients
- Actively immunise patients against their tumours
- Stimulate the patient’s own anti-tumour immune responses
What was the function of monoclonal antibodies against tumour antigens?
Antibodies bind to tumour antigens and either
- activate host effector mechanisms
- deliver toxins to tumour cells
What is “Adoptive cellular immunotherapy”?
T cells contain tumour-specific CTLs (cytotoxic T lymphocytes) which find the tumour and destroy it
Which immune cell is taken from individuals and grown to form tumour vaccines?
Dendritic cells
EXPLANATION: It is hoped that the dendritic cells bearing tumour antigens will mimic the normal pathway of cross-presentation and will generate CTLs against the tumour cells
Which two vaccines are becoming remarkably effective?
- Hepatitis B virus (cause of liver cancer)
- Human papillomavirus (cause of cervical cancer)
How do cytokines boost anti-tumour immune responses?
Treating patients with cytokines that promote lymphocyte activation
EXAMPLE: IL-2 enhances the numbers and functions of regulatory T cells which may interfere with anti-tumour immunity